Patients or their representatives can visit the Institute with a copy of the RAT/RT-PCR report and Aadhar Card or any valid photo ID to receive free AYUSH-64 tablets.
As per the Ministry of AYUSH guidelines, AYUSH-64 will be provided to asymptomatic, mild and moderately affected COVID-19 patients in home isolation. All patients above the age of 18 years, who are not pregnant or lactating can take the medicine.
AYUSH-64 is an Ayurvedic formulation which is developed by the Central Council for Research in Ayurvedic Sciences (CCRAS), the apex body for research in Ayurveda under the Ministry of AYUSH.
The efficacy of the drug in the management of asymptomatic, mild and moderate cases of COVID-19 has been proven and it showed clinically significant improvement, and thus, a lesser period of hospitalisation was reported as compared to the subjects who were on standard care alone.
It has also shown significant beneficial effects on general health, fatigue, anxiety, stress, appetite, general well-being, and sleep, through robust multi-centred clinical trials. AYUSH-64 was also studied in collaboration with the Council of Scientific And Industrial Research as a multicentric study and recently endorsed by the Monitoring Committee OF AYUSH-CSIR.
AYUSH-64 is also recommended in the National Clinical Management of COVID-19 Protocol based on Ayurveda and Yoga.
On May 7, Kiren Rijiju, Minister of Youth Affairs and Sports and Minister(in-charge), Ministry of Ayush, launched a nationwide distribution campaign of AYUSH-64, further information on which can be sought at the Regional Research Institute of Homoeopathy, Bhetapara, or by calling on the numbers 03612306202, 8638969611.